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INTRODUCTION
Ehrlichia canis and Anaplasma phagocytophilum
have been reported to cause disease in animals
and humans. In cats, the ﬁrst evidence for
naturally occurring ehrlichiosis was reported in
France in 1986. Since then, several clinical cases of
feline ehrlichiosis have been described worldwide
and there is molecular and serological evidence of
exposure to these agents in cats. However, no
Ehrlichia species. has been cultured from the
blood of these animals and information available
about attempts to isolate these agents in cats is
limited.
In Spain, different studies on feline ehrlichiosis
and anaplasmosis have shown seroprevalences
ranging from 1.8% to 4.9% for A. phagocytophilum
[1,2], and from 10.6% to 17.9% for E. canis [2,3].
Although Ehrlichia ⁄Anaplasma spp. sequence has
not been obtained yet from cats, DNA from these
species has been ampliﬁed from a sample from a
cat from the Barcelona area [4].
To date, E. canis and A. phagocytophilum isolates
from cats have not been characterised in the
geographic area of Madrid (central Spain).
OBJECTIVES
Our objectives were: to determine the molecular
and serological prevalences of E. canis and
A. phagocytophilum in cats from Madrid, Spain,
grouped as symptomatic and asymptomatic; to
try to isolate E. canis and A. phagocytophilum by
culture of these agents in speciﬁc cell lines; and to
evaluate the existence of associations among
E. canis and A. phagocytophilum infection and
different epidemiological data obtained from each
cat.
MATERIALS AND METHODS
Fifty-two client-owned cats were included in this study. All of
them were treated at the Veterinary Medicine Teaching
Hospital, College of Veterinary Medicine, Complutense Uni-
versity of Madrid, between October 2005 and June 2007, for
different medical or surgical reasons. The animals were
classiﬁed into two different groups: asymptomatic and symp-
tomatic (with clinical signs and laboratory ﬁndings compatible
with Ehrlichia ⁄Anaplasma infection).
In every case, information about breed, sex, habitat, contact
with other animals, arthropod exposure, blood transfusions,
previous treatment with doxycycline, clinical status, laboratory
ﬁndings and FeLV ⁄ FIV status was recorded.
Antibody reactivity against E. canis and A. phagocytophilum
was determined using an indirect immunoﬂuorescence anti-
body (IFA) test. Cut-off was established at an antibody titre of
1:40.
A total of 0.5 mL of sterile blood was cultured in the cell
lines DH82 for E. canis and HL60 for A. phagocytophilum. The
supernatant was stained using a May-Gru¨nwald-Giemsa
technique and checked weekly by microscopic visualisation
to detect the presence of Ehrlichia-like inclusion bodies or
morulae.
A total of 200 lL of whole blood and the supernatant of the
cultures were used for DNA extraction using the ‘Ultra-
CleanTM DNA Blood-Spin Kit’ (Mo Bio Laboratories, Inc.,
Carlsbad, CA 92010, USA).
Ehrlichia spp. and Anaplasma spp. DNA was ampliﬁed
targeting the 16SrRNA gene, using the primer pair GEPs
(5¢CTGGCGGCAAGCYTAACACATGCAAGTCGAACGGA3¢)
and GEPas (5¢CTTCTRTRGGTACCGTCATTATCTTCCCYAY
TG3¢) [5].
Statistical associations among the seropositivity to E. canis
and A. phagocytophilum and the epidemiological data obtained
from each cat were analysed by the chi-square test using the
Statgraphics Centurion XV statistic program.
RESULTS AND DISCUSSION
Antibodies to E. canis and A. phagocytophilumwere
found in two cats (3.8%) and four cats
(7.7%), respectively. Twenty-eight cats were
included in the asymptomatic group and 24 in
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the symptomatic group. Two (8.3%) and one
(4.2%) animals with clinical signs were seroposi-
tive toE. canis andA. phagocytophilum, respectively.
Three of the 28 asymptomatic animals (10.7%)
were A. phagocytophilum seropositive, whereas
none of them was seropositive for E. canis.
These results indicate that there is evidence of
exposure to E. canis and A. phagocytophilum
organisms in the cat population examined at the
Veterinary Medicine Teaching Hospital, College
of Veterinary Medicine, Complutense University
of Madrid. Seroprevalence rate for A. phagocyto-
philum obtained in our study is similar to that
previously described in other studies from Spain
[1,2]. Seroprevalence for E. canis was slightly
lower than in other reports from Spain [1–3],
probably due to the absence of seroreactivity to
E. canis in asymptomatic cats.
There was no statistical association between
seropositivity to either of the two evaluated
agents and the epidemiological data obtained
from that cats, including the presence of clinical
signs compatible with E. canis or A. phagocytophi-
lum infection.
No growth was observed in the stained smears
from the cultures, in accordance with other
studies. Neither Ehrlichia spp. nor Anaplasma
spp. DNA was ampliﬁed from blood and culture
samples.
In our study, Ehrlichia spp. and Anaplasma spp.
seroreactivity was detected in some cats but no
molecular evidence of the presence of these
agents in blood and culture specimens was
found and none of the attempts to isolate any
Ehrlichia ⁄Anaplasma spp. in this population were
successful. Similar results have been obtained
using PCR in other studies [2]. The lack of
ampliﬁcation by PCR in the seropositive samples
could be due to the clearance of the organisms by
the immune system, a sequestration in other
tissues, false negative results of the technique
or serologic cross-reactivity with other agents.
Further studies are needed in order to clarify the
role of cats in Ehrlichia ⁄Anaplasma infection.
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